{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:08:18Z","timestamp":1787162898726,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.hfc.2012.04.009","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T04:32:38Z","timestamp":1337315558000},"page":"447-459","source":"Crossref","is-referenced-by-count":26,"title":["Pulmonary Hypertension Associated with Left-Sided Heart Disease"],"prefix":"10.1016","volume":"8","author":[{"given":"Christopher F.","family":"Barnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.hfc.2012.04.009_bib1","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.hfc.2012.04.009_bib2","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.hfc.2012.04.009_bib3","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2012.04.009_bib4","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ahj.2009.02.022","article-title":"Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database","volume":"157","author":"Khush","year":"2009","journal-title":"Am Heart J"},{"issue":"13","key":"10.1016\/j.hfc.2012.04.009_bib5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study","volume":"53","author":"Lam","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2012.04.009_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0735-1097(92)90050-W","article-title":"Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group","volume":"19","author":"Costard-Jackle","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2012.04.009_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2006.05.021","volume":"48","author":"Bonow","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.009_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM196509022731001","article-title":"Effects of mitral-valve replacement on the pulmonary vascular dynamics of patients with pulmonary hypertension","volume":"273","author":"Braunwald","year":"1965","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2012.04.009_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/CIRCHEARTFAILURE.108.822627","article-title":"Prevalence of left ventricular diastolic dysfunction in a general population","volume":"2","author":"Kuznetsova","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.hfc.2012.04.009_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/eurjhf\/hfq215","article-title":"Heart failure with preserved ejection fraction\u2014a growing epidemic or \u2018The Emperor\u2019s New Clothes?\u2019","volume":"13","author":"Pieske","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.hfc.2012.04.009_bib11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-116-11-888","article-title":"Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy","volume":"116","author":"Abramson","year":"1992","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.hfc.2012.04.009_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/CIRCHEARTFAILURE.111.963785","article-title":"What is the prognostic significance of pulmonary hypertension in heart failure?","volume":"4","author":"Chatterjee","year":"2011","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.hfc.2012.04.009_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/CIRCHEARTFAILURE.110.960864","article-title":"The relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure","volume":"4","author":"Aronson","year":"2011","journal-title":"Circ Heart Fail"},{"issue":"14","key":"10.1016\/j.hfc.2012.04.009_bib14","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1161\/01.CIR.0000013771.30198.82","article-title":"Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk","volume":"105","author":"Cappola","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2012.04.009_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jacc.2011.06.076","article-title":"Pulmonary pressures and death in heart failure: a community study","volume":"59","author":"Bursi","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2012.04.009_bib16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/CIRCHEARTFAILURE.110.959437","article-title":"Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes\/clinical perspective","volume":"4","author":"Lewis","year":"2011","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.hfc.2012.04.009_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/CIRCULATIONAHA.108.802314","article-title":"Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation","volume":"119","author":"Kang","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2012.04.009_bib18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-5223(97)70053-9","article-title":"Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality","volume":"114","author":"Chen","year":"1997","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.hfc.2012.04.009_bib19","first-page":"526","article-title":"Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation","volume":"9","author":"Erickson","year":"1990","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.hfc.2012.04.009_bib20","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","article-title":"Listing criteria for heart transplantation: international society for heart and lung transplantation guidelines for the care of cardiac transplant candidates\u20142006","volume":"25","author":"Mandeep","year":"2006","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.hfc.2012.04.009_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.healun.2003.09.045","article-title":"Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation","volume":"24","author":"Butler","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"11","key":"10.1016\/j.hfc.2012.04.009_bib22","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S1053-2498(99)00070-4","article-title":"Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure","volume":"18","author":"Drazner","year":"1999","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.hfc.2012.04.009_bib23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejheart.2004.10.021","article-title":"Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure","volume":"7","author":"Delgado","year":"2005","journal-title":"Eur J Heart Fail"},{"issue":"14","key":"10.1016\/j.hfc.2012.04.009_bib24","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.102.14.1718","article-title":"Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management","volume":"102","author":"Moraes","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2012.04.009_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial dysfunction in pulmonary hypertension","volume":"109","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2012.04.009_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1378\/chest.109.2.424","article-title":"Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans","volume":"109","author":"Cargill","year":"1996","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hfc.2012.04.009_bib27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.101.5.558","article-title":"Beta-adrenergic receptor blockade in chronic heart failure","volume":"101","author":"Bristow","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2012.04.009_bib28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0735-1097(83)80316-7","article-title":"A\u00a0placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group","volume":"2","year":"1983","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2012.04.009_bib29","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1164\/rccm.200811-1678OC","article-title":"Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension","volume":"179","author":"Ferreira","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.hfc.2012.04.009_bib30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hfc.2012.04.009_bib31","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0002-9149(91)90511-I","article-title":"Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy","volume":"68","author":"Hiroe","year":"1991","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2012.04.009_bib32","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.85.2.504","article-title":"Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure","volume":"85","author":"Cody","year":"1992","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2012.04.009_bib33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0735-1097(95)00520-X","article-title":"Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure","volume":"27","author":"Pacher","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2012.04.009_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"22","author":"Nagueh","year":"2009","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"12","key":"10.1016\/j.hfc.2012.04.009_bib35","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.jacc.2006.07.061","article-title":"Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers","volume":"48","author":"Hoeper","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2012.04.009_bib36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/jama.300.4.431","article-title":"Heart failure with preserved ejection fraction: treat now by treating comorbidities","volume":"300","author":"Shah","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.hfc.2012.04.009_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","article-title":"A\u00a0randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.hfc.2012.04.009_bib38","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.287.12.1531","article-title":"Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure","volume":"287","author":"Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.hfc.2012.04.009_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cardfail.2005.01.009","article-title":"Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension","volume":"11","author":"Michaels","year":"2005","journal-title":"J\u00a0Card Fail"},{"issue":"21","key":"10.1016\/j.hfc.2012.04.009_bib40","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIR.0b013e318200c0b5","article-title":"2010 clinical trial\/clinical science abstracts","volume":"122","year":"2010","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.hfc.2012.04.009_bib41","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.hfc.2012.04.009_bib42","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1053\/euhj.2000.2557","article-title":"Endothelin antagonists for chronic heart failure: do they have a role?","volume":"22","author":"Cowburn","year":"2001","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hfc.2012.04.009_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/hrt.2006.089250","article-title":"Clinical trials of endothelin antagonists in heart failure: publication is good for the public health","volume":"93","author":"Kelland","year":"2007","journal-title":"Heart"},{"issue":"21","key":"10.1016\/j.hfc.2012.04.009_bib44","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.98.21.2262","article-title":"Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure","volume":"98","author":"Sutsch","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2012.04.009_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardfail.2004.05.006","article-title":"Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study","volume":"11","author":"Packer","year":"2005","journal-title":"J\u00a0Card Fail"},{"issue":"3","key":"10.1016\/j.hfc.2012.04.009_bib46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1054\/jcaf.2002.126486","article-title":"Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): approaching the asymptote of efficacy?","volume":"8","author":"Teerlink","year":"2002","journal-title":"J\u00a0Card Fail"},{"issue":"2\u20133","key":"10.1016\/j.hfc.2012.04.009_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0167-5273(02)00182-1","article-title":"Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?","volume":"85","author":"Kalra","year":"2002","journal-title":"Int J Cardiol"},{"issue":"21","key":"10.1016\/j.hfc.2012.04.009_bib48","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/01.CIR.0000038497.80095.E1","article-title":"Hemodynamic and neurohumoral effects of selective endothelin A (ETA) receptor blockade in chronic heart failure: the heart failure ETA receptor blockade trial (HEAT)","volume":"106","author":"Luscher","year":"2002","journal-title":"Circulation"},{"issue":"9431","key":"10.1016\/j.hfc.2012.04.009_bib49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(04)16723-8","article-title":"Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Anand","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.hfc.2012.04.009_bib50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0735-1097(02)02708-0","article-title":"RITZ-5: randomized intravenous TeZosentan (an endothelin-A\/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study","volume":"41","author":"Kaluski","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2012.04.009_bib51","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/vhrm.2006.2.4.411","article-title":"Sildenafil in the treatment of pulmonary hypertension","volume":"2","author":"Barnett","year":"2006","journal-title":"Vasc Health Risk Manag"},{"issue":"20","key":"10.1016\/j.hfc.2012.04.009_bib52","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.hfc.2012.04.009_bib53","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hfc.2012.04.009_bib54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrcardio.2009.32","article-title":"Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications","volume":"6","author":"Kumar","year":"2009","journal-title":"Nat Rev Cardiol"},{"issue":"22","key":"10.1016\/j.hfc.2012.04.009_bib55","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.jacc.2007.07.075","article-title":"Type 5 phosphodiesterase inhibition in heart failure: the next step","volume":"50","author":"Goldsmith","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2012.04.009_bib56","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.amjcard.2004.07.157","article-title":"Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure","volume":"94","author":"Alaeddini","year":"2004","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2012.04.009_bib57","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1378\/chest.127.5.1647","article-title":"Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide","volume":"127","author":"Lepore","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.hfc.2012.04.009_bib58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.106.626226","article-title":"Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure","volume":"115","author":"Lewis","year":"2007","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.hfc.2012.04.009_bib59","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.jacc.2007.07.078","article-title":"Long-term use of sildenafil in the therapeutic management of heart failure","volume":"50","author":"Guazzi","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2012.04.009_bib60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCHEARTFAILURE.110.944694","article-title":"PDE5-inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry and clinical status in patients with stable systolic heart failure: results of\u00a0a 1-year prospective, randomized, placebo-controlled study","volume":"4","author":"Guazzi","year":"2011","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.hfc.2012.04.009_bib61","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/eurjhf\/hfr147","article-title":"Phosphodiesterase 5\u00a0inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study","volume":"14","author":"Guazzi","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.hfc.2012.04.009_bib62","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction\/clinical perspective","volume":"124","author":"Guazzi","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hfc.2012.04.009_bib63","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.athoracsur.2006.05.114","article-title":"Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant","volume":"82","author":"Klotz","year":"2006","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.hfc.2012.04.009_bib64","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jtcvs.2010.05.042","article-title":"Regression of \u201cfixed\u201d pulmonary vascular resistance in heart transplant candidates after unloading with ventricular assist devices","volume":"140","author":"Beyersdorf","year":"2010","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.hfc.2012.04.009_bib65","first-page":"291","article-title":"Oral sildenafil: potential role in heart transplantation. Review of the literature and personal experience","volume":"55","author":"Sansone","year":"2010","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.hfc.2012.04.009_bib66","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1600-6143.2007.01783.x","article-title":"Heart and lung transplantation in the United States, 1996\u20132005","volume":"7","author":"Garrity","year":"2007","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.hfc.2012.04.009_bib67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.athoracsur.2010.01.023","article-title":"Review of heart-lung transplantation at Stanford","volume":"90","author":"Deuse","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.hfc.2012.04.009_bib68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.healun.2009.09.013","article-title":"Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension","volume":"29","author":"Nair","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.hfc.2012.04.009_bib69","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejcts.2006.12.036","article-title":"Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices","volume":"31","author":"Zimpfer","year":"2007","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713612000335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713612000335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T05:26:46Z","timestamp":1542950806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713612000335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1551713612000335"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2012.04.009","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}